Posted on February 7, 2019 by Sitemaster
It has long been appreciated that African-American males have higher risk for diagnosis with prostate cancer, and higher risk for prostate cancer-specific mortality, than those of other ethnic origins living in the US. … READ MORE …
Filed under: Uncategorized | Tagged: African American, aggressiveness, decision-making, disparity, race, Treatment, white | 7 Comments »
Posted on October 5, 2016 by Sitemaster
A new article in Urology (“the Gold Journal”) has again pointed out the race-related discrepancies between the application of definitive treatments for prostate cancer, particularly between Caucasian-American and African-American men. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: disparity, race, risk, Treatment | 1 Comment »
Posted on October 18, 2015 by Sitemaster
A newly published paper in the Journal of the National Comprehensive Cancer Network has identified a series of significant disparities in there clinical care of African American men as opposed to Caucasians. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: care, disparity, end of life, intensity, quality | Leave a comment »
Posted on August 8, 2011 by Sitemaster
As reported last Friday on the Medscape web site, the American Society for Clinical Oncology (ASCO) has recently issued a new policy statement addressing the opportunities presented by the Patient Protection and Affordable Care Act (PPACA) to reduce the disparities in cancer care. … READ MORE …
Filed under: Uncategorized | Tagged: care, disparity | Leave a comment »
Posted on November 19, 2008 by Sitemaster
Today’s reports cover such items as:
- Disparities in cancer mortality between blacks and whites in the USA
- Body mass, body fat distribution, and risk for prostate cancer
- Risk for cancer in male carriers of BRCA mutations
- A five-SNP genetic marker set and prostate cancer risk
- Final results of the atrasentan trial in non-metastatic, HRPC patients
- Is a rising plasma PDGF level an indicator for docetaxel failure? … READ MORE …
Filed under: Drugs in development, Management, Prevention, Treatment | Tagged: atrasentan, BMI, BRCA mutation, disparity, docetaxel, fat distribution, genetic marker, PGDF, SNP | Leave a comment »